BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2950941)

  • 1. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
    Bini A; Fenoglio J; Sobel J; Owen J; Fejgl M; Kaplan KL
    Blood; 1987 Apr; 69(4):1038-45. PubMed ID: 2950941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptides A and B release in the process of surface fibrin formation.
    Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
    Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen proteolysis by thrombin, plasmin and platelet release in relation to disseminated intravascular coagulation.
    Nossel HL
    Bibl Haematol; 1983; (49):151-62. PubMed ID: 6230075
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene.
    Liu CY; Koehn JA; Morgan FJ
    J Biol Chem; 1985 Apr; 260(7):4390-6. PubMed ID: 3156856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of 'B-b' knob-hole interactions in fibrin binding to adsorbed fibrinogen.
    Geer CB; Tripathy A; Schoenfisch MH; Lord ST; Gorkun OV
    J Thromb Haemost; 2007 Dec; 5(12):2344-51. PubMed ID: 17892530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step fibrinogen--fibrin transition in blood coagulation.
    Blombäck B; Hessel B; Hogg D; Therkildsen L
    Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
    Pechik I; Yakovlev S; Mosesson MW; Gilliland GL; Medved L
    Biochemistry; 2006 Mar; 45(11):3588-97. PubMed ID: 16533041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.
    Lewis SD; Shields PP; Shafer JA
    J Biol Chem; 1985 Aug; 260(18):10192-9. PubMed ID: 4019507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of fibrinogen in human arterial intima.
    Smith EB; Keen GA; Grant A; Stirk C
    Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen derivatives in plasma.
    Lane DA
    Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
    [No Abstract]   [Full Text] [Related]  

  • 19. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.